[go: nahoru, domu]
Jump to content

The Medical Letter on Drugs and Therapeutics: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
 
(33 intermediate revisions by 17 users not shown)
Line 1: Line 1:
{{more citations needed|date=April 2016}}
{{Infobox journal
{{Infobox journal
| cover = <!-- Commented out because image was deleted: [[image:tml_on_drugs_w-website.gif|200px|center]] -->
| cover = <!-- Commented out because image was deleted: [[image:tml on drugs w-website.gif|200px|center]] -->
| discipline = [[Publication]]
| discipline = [[Pharmacology]]
| language = English, French, Italian
| language = [[English language|English]], [[French language|French]], [[Italian language|Italian]], [[Japanese language|Japanese]], [[Spanish language|Spanish]] and a Canadian adapted version, written in English
| abbreviation = Med Lett Drugs Ther
| abbreviation = Med. Lett. Drugs Ther.
| publisher = [[The Medical Letter, Inc.]]
| publisher = [[The Medical Letter, Inc.]]
| country = [[USA]]
| country =
| history = first published 1959
| history = 1959-present
| frequency = Biweekly
| website = http://www.medicalletter.org/
| website = http://secure.medicalletter.org/medicalletter
| ISSN = 1523-2859
| ISSN = 1523-2859
| OCLC = 40606056
| LCCN = 00211546
| CODEN = MELEAP
}}
}}
'''''The Medical Letter on Drugs and Therapeutics''''' (commonly referred to as ''The Medical Letter'') is a [[Peer review|peer-reviewed]] biweekly [[medical journal]] providing evaluations of [[pharmaceutical drug]]s. It is published in English, French, and Italian. The journal is abstracted and indexed in [[Index medicus]]/[[MEDLINE]]/[[PubMed]]. An offshoot, ''Treatment Guidelines from the Medical Letter'' ({{ISSN|1541-2792}}) was published from 2002 to 2014, when it was integrated into this journal.

The Medical Letter on Drugs and Therapeutics (usually referred to as The Medical Letter) is the non-profit publisher of The Medical Letter and Treatment Guidelines from The Medical Letter. Both publications offer health care professionals independent evaluations of therapeutic drugs. The Medical Letter is supported entirely by sales of its print and electronic publications. It does not accept advertisements, gifts, grants or donations, and does not accept bulk orders for reprints of its contents.

The Medical Letter has a print plus electronic circulation of more than 450,000 subscribers in 125 countries worldwide. Published biweekly (Treatment Guidelines is published monthly), it is available in several languages: [[English language|English]] (US and Canadian editions), [[French language|French]] (Canadian and European editions), [[Italian language|Italian]], [[Japanese language|Japanese]], and [[Spanish language|Spanish]].The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices.



== Editorial process ==
== Editorial process ==
Articles for The Medical Letter are drafted by either an in-house editor or an outside consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of clinical trials. A preliminary draft is circulated to 10-20 medical investigators with relevant clinical or experimental experience. Drafts are also sent to the Food and Drug Administration (FDA) the first authors of all the articles cited in the text, to the pharmaceutical companies that make the drug(s) under review, and to the manufacturers of competing drugs. The evaluation of each drug includes a discussion of its effectiveness, side effects, and a comparison with other agents used for the same indication. The final version of the paper incorporates comments from the reviewers, and the final version is checked and edited for accuracy and readability.<ref>{{cite web | url = http://medlet-best.securesites.com/downloads/Editorialchart.pdf | title = Flowchart of the editorial process | accessdate = 2010-06-29 | publisher = [[The Medical Letter, Inc.]] | format = pdf }}</ref>
Articles for ''The Medical Letter'' are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of [[clinical trial]]s. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the [[Food and Drug Administration]] and [[Centers for Disease Control and Prevention]] and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.<ref>{{cite web |url=http://medlet-best.securesites.com/downloads/Editorialchart.pdf |title=Flowchart of the editorial process |accessdate=2010-06-29 |publisher=[[The Medical Letter, Inc.]] |format=PDF}}</ref>


== See also ==
== Publisher ==
The journal is published by The Medical Letter, Inc., a [[nonprofit organization]] founded in 1958 by [[Arthur Kallet]] and Harold Aaron.<ref>{{Cite journal |title=The Medical Letter - 50th Anniversary |url=https://secure.medicalletter.org/TML-article-1304d |journal=The Medical Letter on Drugs and Therapeutics |publication-date=2009 |volume=51 |issue=1304 |pages=5}}</ref> It is independent of the pharmaceutical industry, supported by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.{{citation needed|date=April 2016}}
⚫
* [[List of medical journals]]


==References==
== References ==
{{Reflist}}
{{Reflist}}


==External links==
== External links ==
* [http://www.medicalletter.org The Medical Letter website]
* {{Official website|http://secure.medicalletter.org/medicalletter}}



{{DEFAULTSORT:Medical Letter on Drugs and Therapeutics}}
{{DEFAULTSORT:Medical Letter on Drugs and Therapeutics}}
[[Category:Publications established in 1959]]
[[Category:Academic journals established in 1959]]
[[Category:Pharmacology journals]]
[[Category:Pharmacology journals]]
[[Category:Multilingual journals]]
[[Category:English-language journals]]
[[Category:French-language journals]]
[[Category:Italian-language journals]]
[[Category:English-Italian multilingual journals]]
⚫
[[Category:Biweekly journals]]

Latest revision as of 17:53, 6 January 2024

The Medical Letter on Drugs and Therapeutics
DisciplinePharmacology
LanguageEnglish, French, Italian
Publication details
History1959-present
Publisher
FrequencyBiweekly
Standard abbreviations
ISO 4Med. Lett. Drugs Ther.
Indexing
CODENMELEAP
ISSN1523-2859
LCCN00211546
OCLC no.40606056
Links

The Medical Letter on Drugs and Therapeutics (commonly referred to as The Medical Letter) is a peer-reviewed biweekly medical journal providing evaluations of pharmaceutical drugs. It is published in English, French, and Italian. The journal is abstracted and indexed in Index medicus/MEDLINE/PubMed. An offshoot, Treatment Guidelines from the Medical Letter (ISSN 1541-2792) was published from 2002 to 2014, when it was integrated into this journal.

Editorial process

[edit]

Articles for The Medical Letter are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of clinical trials. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the Food and Drug Administration and Centers for Disease Control and Prevention and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.[1]

Publisher

[edit]

The journal is published by The Medical Letter, Inc., a nonprofit organization founded in 1958 by Arthur Kallet and Harold Aaron.[2] It is independent of the pharmaceutical industry, supported by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.[citation needed]

References

[edit]
  1. ^ "Flowchart of the editorial process" (PDF). The Medical Letter, Inc. Retrieved 2010-06-29.
  2. ^ "The Medical Letter - 50th Anniversary". The Medical Letter on Drugs and Therapeutics. 51 (1304): 5. 2009.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=The_Medical_Letter_on_Drugs_and_Therapeutics&oldid=1193995794"